The Modified APC Resistance Test in the Presence of Factor V Deficient Plasma Can Be Used in Patients without Oral Anticoagulant

• References

• 1 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
• 2 Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-1163
• 3 Trossaërt M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, Lane D. Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709
• 4 Tosetto A, Rodeghiero F. Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thromb Haemost 1995; 73: 732-733
• 5 Cadroy Y, Sié P, Alhenc-Gelas M, Aiach M. Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants. Thromb Haemost 1995; 73: 734-735
• 6 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PE, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 7 Dahlbäck B. Resistance to activated protein C, the Arg⁵⁰⁶ to Gin mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995; 73: 739-742